project id: TCGA-COAD; case submitter id: TCGA-AA-3664; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 9.3; spectrophotometer method: UV Spec; age at index: 74; days to birth: -27363; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1931; age at diagnosis: 27363; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T3; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1643.0; icd 10 code: C18.2; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cecum; synchronous malignancy: No; tissue or organ of origin: Ascending colon; tumor grade: Not Reported; year of diagnosis: 2005; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 1.0; longest dimension: 1.0; oct embedded: No; shortest dimension: 0.6; portion submitter id: TCGA-AA-3664-01A-01; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 5.0; percent necrosis: 0.0; percent neutrophil infiltration: 50.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0;